FDA Review #2015 FDA Approved DrugsUpdate-1 4 years ago Dr Rakesh Sonawane Tags: 2015, CVS, DRUGSREVIEW, FDA, SERIES-1 Continue Reading Previous FDA approves IL-5 Antagonist, Cinqair (reslizumab) to treat severe asthma.Next FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow.
